1: Nakano MM, Lin A, Zuber CS, Newberry KJ, Brennan RG, Zuber P. Promoter
recognition by a complex of Spx and the C-terminal domain of the RNA polymerase
alpha subunit. PLoS One. 2010 Jan 13;5(1):e8664. PubMed PMID: 20084284; PubMed
Central PMCID: PMC2801614.

2: Black S, Eskola J, Siegrist CA, Halsey N, Macdonald N, Law B, Miller E,
Andrews N, Stowe J, Salmon D, Vannice K, Izurieta HS, Akhtar A, Gold M, Oselka G,
Zuber P, Pfeifer D, Vellozzi C. Importance of background rates of disease in
assessment of vaccine safety during mass immunisation with pandemic H1N1
influenza vaccines. Lancet. 2009 Dec 19;374(9707):2115-22. Epub 2009 Oct 31.
Erratum in: Lancet. 2010 Jan 30;375(9712):376. PubMed PMID: 19880172.

3: Patel MM, Haber P, Baggs J, Zuber P, Bines JE, Parashar UD. Intussusception
and rotavirus vaccination: a review of the available evidence. Expert Rev
Vaccines. 2009 Nov;8(11):1555-64. Review. PubMed PMID: 19863248.

4: Zuber P. Management of oxidative stress in Bacillus. Annu Rev Microbiol.
2009;63:575-97. Review. PubMed PMID: 19575568.

5: Garg SK, Kommineni S, Henslee L, Zhang Y, Zuber P. The YjbH protein of
Bacillus subtilis enhances ClpXP-catalyzed proteolysis of Spx. J Bacteriol. 2009 
Feb;191(4):1268-77. Epub 2008 Dec 12. PubMed PMID: 19074380; PubMed Central
PMCID: PMC2632004.

6: Zuber PL, Dumolard L, Shirey M, Rizzo I, Marshall J. Forecasting demand for
Hib-containing vaccine in the world's poorest countries: a 4-year prospective
experience. Vaccine. 2009 Jan 14;27(3):410-5. Epub 2008 Nov 14. PubMed PMID:
19013493.

7: Reyes DY, Zuber P. Activation of transcription initiation by Spx: formation of
transcription complex and identification of a Cis-acting element required for
transcriptional activation. Mol Microbiol. 2008 Aug;69(3):765-79. PubMed PMID:
18687074; PubMed Central PMCID: PMC2758557.

8: Zuber PJ, Bart AP, Leimgruber A, Spertini F. [Behçet's disease: from
hippocrates to TNF-alpha-blockers]. Rev Med Suisse. 2008 Apr 23;4(154):1045-8,
1050-4. Review. French. PubMed PMID: 18557534.

9: Lee EH, Lewis RF, Makumbi I, Kekitiinwa A, Ediamu TD, Bazibu M, Braka F,
Flannery B, Zuber PL, Feikin DR. Haemophilus influenzae type b conjugate vaccine 
is highly effective in the Ugandan routine immunization program: a case-control
study. Trop Med Int Health. 2008 Apr;13(4):495-502. Epub 2008 Feb 25. PubMed
PMID: 18312475.

10: Antelmann H, Hecker M, Zuber P. Proteomic signatures uncover thiol-specific
electrophile resistance mechanisms in Bacillus subtilis. Expert Rev Proteomics.
2008 Feb;5(1):77-90. Review. PubMed PMID: 18282125.

11: Leelakriangsak M, Huyen NT, Töwe S, van Duy N, Becher D, Hecker M, Antelmann 
H, Zuber P. Regulation of quinone detoxification by the thiol stress sensing
DUF24/MarR-like repressor, YodB in Bacillus subtilis. Mol Microbiol. 2008
Mar;67(5):1108-24. Epub 2008 Jan 16. PubMed PMID: 18208493.

12: Zhang Y, Zuber P. Requirement of the zinc-binding domain of ClpX for Spx
proteolysis in Bacillus subtilis and effects of disulfide stress on ClpXP
activity. J Bacteriol. 2007 Nov;189(21):7669-80. Epub 2007 Sep 7. PubMed PMID:
17827297; PubMed Central PMCID: PMC2168722.

13: Rossi IA, Zuber PL, Dumolard L, Walker DG, Watt J. Introduction of Hib
vaccine into national immunization programmes: a descriptive analysis of global
trends. Vaccine. 2007 Oct 10;25(41):7075-80. Epub 2007 Aug 15. PubMed PMID:
17825458.

14: Töwe S, Leelakriangsak M, Kobayashi K, Van Duy N, Hecker M, Zuber P,
Antelmann H. The MarR-type repressor MhqR (YkvE) regulates multiple
dioxygenases/glyoxalases and an azoreductase which confer resistance to
2-methylhydroquinone and catechol in Bacillus subtilis. Mol Microbiol. 2007
Oct;66(1):40-54. Epub 2007 Aug 27. PubMed PMID: 17725564.